Michael Hayden Rosenthal, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatic Neoplasms | 20 | 2024 | 5442 | 1.870 |
Why?
|
Carcinoma, Pancreatic Ductal | 8 | 2024 | 1756 | 0.990 |
Why?
|
Tomography, X-Ray Computed | 27 | 2022 | 20762 | 0.980 |
Why?
|
Adenocarcinoma | 8 | 2022 | 6395 | 0.780 |
Why?
|
Body Composition | 7 | 2023 | 2462 | 0.740 |
Why?
|
Rectal Neoplasms | 3 | 2019 | 1183 | 0.710 |
Why?
|
Radiography, Abdominal | 1 | 2020 | 541 | 0.570 |
Why?
|
Pancreas | 3 | 2022 | 1699 | 0.520 |
Why?
|
Outpatients | 2 | 2022 | 1600 | 0.520 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2015 | 100 | 0.480 |
Why?
|
Early Detection of Cancer | 3 | 2024 | 3239 | 0.440 |
Why?
|
Anus Neoplasms | 2 | 2019 | 336 | 0.410 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 520 | 0.400 |
Why?
|
Colorectal Neoplasms | 7 | 2024 | 6975 | 0.360 |
Why?
|
Neoplasm Staging | 8 | 2022 | 11244 | 0.350 |
Why?
|
Diagnostic Imaging | 8 | 2024 | 3533 | 0.340 |
Why?
|
ras Proteins | 1 | 2014 | 1058 | 0.330 |
Why?
|
Stomach Neoplasms | 2 | 2017 | 1481 | 0.320 |
Why?
|
Cellulitis | 1 | 2011 | 206 | 0.320 |
Why?
|
Fractures, Spontaneous | 1 | 2010 | 232 | 0.310 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 89 | 0.300 |
Why?
|
Abscess | 1 | 2011 | 606 | 0.280 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 3 | 2018 | 498 | 0.270 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2010 | 326 | 0.270 |
Why?
|
Femoral Fractures | 1 | 2010 | 376 | 0.270 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2020 | 9016 | 0.270 |
Why?
|
Sarcopenia | 2 | 2021 | 378 | 0.260 |
Why?
|
Neck | 1 | 2011 | 736 | 0.260 |
Why?
|
Diagnosis, Differential | 9 | 2019 | 13013 | 0.230 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2024 | 1767 | 0.230 |
Why?
|
Testicular Neoplasms | 3 | 2015 | 806 | 0.220 |
Why?
|
Femur | 1 | 2010 | 1321 | 0.220 |
Why?
|
Proto-Oncogene Proteins | 2 | 2023 | 4528 | 0.220 |
Why?
|
Molecular Targeted Therapy | 4 | 2015 | 2830 | 0.220 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2014 | 304 | 0.210 |
Why?
|
Positron-Emission Tomography | 4 | 2015 | 6669 | 0.210 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2015 | 4058 | 0.210 |
Why?
|
Bacterial Infections | 1 | 2011 | 1397 | 0.200 |
Why?
|
Humans | 68 | 2024 | 768171 | 0.200 |
Why?
|
Terminology as Topic | 2 | 2019 | 1542 | 0.200 |
Why?
|
Bone Neoplasms | 2 | 2014 | 2565 | 0.200 |
Why?
|
User-Computer Interface | 3 | 2008 | 1407 | 0.180 |
Why?
|
Histiocytes | 1 | 2021 | 97 | 0.180 |
Why?
|
Weight Loss | 2 | 2024 | 2721 | 0.180 |
Why?
|
Biopsy, Needle | 2 | 2003 | 1623 | 0.180 |
Why?
|
Computer Graphics | 1 | 2002 | 344 | 0.180 |
Why?
|
Ultrasonography, Mammary | 1 | 2002 | 243 | 0.180 |
Why?
|
Radiology | 4 | 2022 | 2104 | 0.170 |
Why?
|
Stroke | 1 | 2022 | 9755 | 0.170 |
Why?
|
Artificial Intelligence | 3 | 2023 | 2666 | 0.160 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2022 | 631 | 0.160 |
Why?
|
Adipose Tissue | 3 | 2023 | 3334 | 0.160 |
Why?
|
Cholangiocarcinoma | 2 | 2014 | 561 | 0.160 |
Why?
|
Bile Duct Neoplasms | 2 | 2014 | 614 | 0.160 |
Why?
|
Muscle, Skeletal | 4 | 2023 | 4978 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 7 | 2019 | 36741 | 0.150 |
Why?
|
Peritoneal Neoplasms | 2 | 2014 | 714 | 0.150 |
Why?
|
Tumor Escape | 1 | 2021 | 372 | 0.150 |
Why?
|
Middle Aged | 29 | 2024 | 223487 | 0.150 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 2018 | 84 | 0.140 |
Why?
|
Soft Tissue Neoplasms | 3 | 2015 | 1164 | 0.140 |
Why?
|
Hepatic Artery | 1 | 2018 | 232 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 2 | 2018 | 4064 | 0.140 |
Why?
|
Anal Canal | 2 | 2019 | 376 | 0.140 |
Why?
|
Fluorouracil | 2 | 2019 | 1652 | 0.140 |
Why?
|
Thyroid Neoplasms | 1 | 2010 | 2360 | 0.140 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15662 | 0.130 |
Why?
|
DNA Mismatch Repair | 1 | 2019 | 431 | 0.130 |
Why?
|
Sarcoma | 3 | 2016 | 1806 | 0.130 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2019 | 646 | 0.130 |
Why?
|
Sex Distribution | 1 | 2020 | 2278 | 0.120 |
Why?
|
Calculi | 1 | 2015 | 48 | 0.120 |
Why?
|
Abdomen | 1 | 2021 | 1136 | 0.120 |
Why?
|
Radiography | 3 | 2021 | 6986 | 0.120 |
Why?
|
Male | 33 | 2024 | 364731 | 0.120 |
Why?
|
Hormone Antagonists | 1 | 2015 | 108 | 0.120 |
Why?
|
Retrospective Studies | 12 | 2022 | 81760 | 0.120 |
Why?
|
Pancreatectomy | 1 | 2019 | 825 | 0.120 |
Why?
|
Rectum | 2 | 2019 | 900 | 0.120 |
Why?
|
Age Distribution | 1 | 2020 | 2873 | 0.120 |
Why?
|
Neoplasms | 6 | 2024 | 22371 | 0.120 |
Why?
|
Lung Neoplasms | 4 | 2023 | 13586 | 0.120 |
Why?
|
Liposarcoma, Myxoid | 1 | 2015 | 60 | 0.120 |
Why?
|
Duodenal Neoplasms | 1 | 2015 | 114 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 542 | 0.120 |
Why?
|
Myxoma | 1 | 2015 | 114 | 0.110 |
Why?
|
Lymphatic Metastasis | 3 | 2019 | 2914 | 0.110 |
Why?
|
Esophageal Neoplasms | 2 | 2015 | 1668 | 0.110 |
Why?
|
Lymphatic System | 1 | 2015 | 251 | 0.110 |
Why?
|
Mutation | 4 | 2024 | 30237 | 0.110 |
Why?
|
Gastrointestinal Diseases | 1 | 2022 | 1205 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1320 | 0.110 |
Why?
|
Genomics | 2 | 2021 | 5926 | 0.110 |
Why?
|
Bone Marrow Neoplasms | 1 | 2014 | 101 | 0.110 |
Why?
|
Pancreatic Ducts | 1 | 2015 | 330 | 0.110 |
Why?
|
Reference Values | 1 | 2020 | 4939 | 0.110 |
Why?
|
Penile Neoplasms | 1 | 2015 | 158 | 0.110 |
Why?
|
Female | 27 | 2024 | 397187 | 0.100 |
Why?
|
Tumor Virus Infections | 1 | 2015 | 437 | 0.100 |
Why?
|
Seminoma | 1 | 2013 | 136 | 0.100 |
Why?
|
Gastrointestinal Stromal Tumors | 2 | 2015 | 617 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2894 | 0.100 |
Why?
|
Hepatitis B Virus, Woodchuck | 1 | 2011 | 6 | 0.100 |
Why?
|
Survival Analysis | 4 | 2021 | 10099 | 0.100 |
Why?
|
Osteoporosis | 1 | 2021 | 1605 | 0.100 |
Why?
|
Neuroendocrine Tumors | 2 | 2015 | 657 | 0.100 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 319 | 0.100 |
Why?
|
Observer Variation | 2 | 2014 | 2621 | 0.100 |
Why?
|
Cachexia | 2 | 2023 | 202 | 0.090 |
Why?
|
Edema | 1 | 2015 | 765 | 0.090 |
Why?
|
Hormones | 1 | 2015 | 866 | 0.090 |
Why?
|
Teratoma | 1 | 2014 | 405 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 1437 | 0.090 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2011 | 189 | 0.090 |
Why?
|
Elasticity Imaging Techniques | 1 | 2015 | 398 | 0.090 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8542 | 0.090 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1791 | 0.090 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1132 | 0.090 |
Why?
|
Antineoplastic Agents | 4 | 2024 | 13677 | 0.090 |
Why?
|
Neoplasm Metastasis | 3 | 2015 | 4913 | 0.080 |
Why?
|
Ultrasonography | 4 | 2016 | 6004 | 0.080 |
Why?
|
Fatal Outcome | 2 | 2014 | 1836 | 0.080 |
Why?
|
Papillomaviridae | 1 | 2015 | 1140 | 0.080 |
Why?
|
Carcinoma, Basal Cell | 1 | 2015 | 565 | 0.080 |
Why?
|
Lymphoma, Follicular | 1 | 2013 | 460 | 0.080 |
Why?
|
Aged | 18 | 2024 | 171502 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20225 | 0.080 |
Why?
|
Drug Monitoring | 1 | 2015 | 964 | 0.080 |
Why?
|
Surgery, Oral | 1 | 2011 | 133 | 0.080 |
Why?
|
Lymphoma | 2 | 2014 | 1898 | 0.080 |
Why?
|
Aged, 80 and over | 9 | 2020 | 59626 | 0.080 |
Why?
|
Angiogenesis Inhibitors | 2 | 2015 | 2057 | 0.080 |
Why?
|
Thromboembolism | 1 | 2014 | 1004 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2907 | 0.070 |
Why?
|
Computer Terminals | 1 | 2008 | 41 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3706 | 0.070 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3620 | 0.070 |
Why?
|
Membrane Proteins | 1 | 2024 | 7876 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2015 | 3517 | 0.070 |
Why?
|
Contrast Media | 4 | 2015 | 5330 | 0.070 |
Why?
|
Prognosis | 5 | 2021 | 30009 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1536 | 0.070 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 1679 | 0.070 |
Why?
|
Marketing of Health Services | 1 | 2007 | 151 | 0.070 |
Why?
|
Catheter Ablation | 2 | 2011 | 2780 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5432 | 0.070 |
Why?
|
Radionuclide Imaging | 1 | 2010 | 2000 | 0.070 |
Why?
|
Hepatitis B | 1 | 2011 | 711 | 0.060 |
Why?
|
Risk Factors | 4 | 2023 | 74944 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 9540 | 0.060 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39354 | 0.060 |
Why?
|
Thyroidectomy | 1 | 2010 | 913 | 0.060 |
Why?
|
Reminder Systems | 1 | 2007 | 388 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2846 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5341 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6568 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1640 | 0.050 |
Why?
|
Patient Selection | 1 | 2015 | 4260 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10266 | 0.050 |
Why?
|
Carcinoma | 1 | 2014 | 2332 | 0.050 |
Why?
|
Equipment Design | 3 | 2011 | 3522 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6610 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2015 | 2334 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26379 | 0.050 |
Why?
|
Body Weight | 2 | 2024 | 4627 | 0.050 |
Why?
|
Hemorrhage | 1 | 2014 | 3466 | 0.050 |
Why?
|
Adult | 13 | 2020 | 223646 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2541 | 0.050 |
Why?
|
Inflammation | 1 | 2022 | 10873 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14729 | 0.050 |
Why?
|
Head | 1 | 2008 | 926 | 0.050 |
Why?
|
Privacy | 1 | 2023 | 233 | 0.050 |
Why?
|
Population Surveillance | 2 | 2024 | 2596 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2023 | 15453 | 0.050 |
Why?
|
Cohort Studies | 2 | 2020 | 41753 | 0.050 |
Why?
|
Intention | 1 | 2024 | 347 | 0.050 |
Why?
|
GTP Phosphohydrolases | 1 | 2024 | 525 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12543 | 0.040 |
Why?
|
Palliative Care | 1 | 2015 | 3643 | 0.040 |
Why?
|
Muscular Atrophy | 1 | 2023 | 335 | 0.040 |
Why?
|
Mass Screening | 2 | 2024 | 5458 | 0.040 |
Why?
|
Genotype | 1 | 2014 | 13045 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 11879 | 0.040 |
Why?
|
Models, Anatomic | 1 | 2002 | 680 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5704 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11878 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2021 | 375 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2003 | 21207 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9419 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9262 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2007 | 2337 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5717 | 0.030 |
Why?
|
Risk Assessment | 1 | 2018 | 24318 | 0.030 |
Why?
|
Liver Neoplasms | 2 | 2015 | 4363 | 0.030 |
Why?
|
Frail Elderly | 1 | 2021 | 781 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5863 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2016 | 408 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2021 | 937 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2023 | 1996 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2016 | 297 | 0.030 |
Why?
|
Anemia, Myelophthisic | 1 | 2014 | 6 | 0.030 |
Why?
|
Leucovorin | 1 | 2016 | 643 | 0.030 |
Why?
|
Fibromatosis, Aggressive | 1 | 2016 | 125 | 0.030 |
Why?
|
Pancreaticoduodenectomy | 1 | 2018 | 516 | 0.030 |
Why?
|
Tumor Lysis Syndrome | 1 | 2014 | 38 | 0.030 |
Why?
|
Preoperative Period | 1 | 2016 | 565 | 0.030 |
Why?
|
Cholangiography | 1 | 2014 | 182 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2433 | 0.030 |
Why?
|
Spermatocytes | 1 | 2013 | 40 | 0.030 |
Why?
|
Mesenchymoma | 1 | 2014 | 50 | 0.030 |
Why?
|
Learning | 1 | 2023 | 1759 | 0.030 |
Why?
|
Penis | 1 | 2015 | 209 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2059 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2002 | 2512 | 0.030 |
Why?
|
Ascites | 1 | 2015 | 338 | 0.030 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2014 | 187 | 0.030 |
Why?
|
Pericardial Effusion | 1 | 2015 | 246 | 0.030 |
Why?
|
Piperazines | 1 | 2024 | 2554 | 0.030 |
Why?
|
Peritoneum | 1 | 2014 | 230 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2029 | 0.030 |
Why?
|
Bile Ducts | 1 | 2014 | 288 | 0.030 |
Why?
|
Rhabdomyosarcoma | 1 | 2016 | 358 | 0.030 |
Why?
|
Pleural Effusion | 1 | 2015 | 344 | 0.020 |
Why?
|
Marmota | 1 | 2011 | 13 | 0.020 |
Why?
|
Duodenum | 1 | 2015 | 495 | 0.020 |
Why?
|
Pyrimidines | 1 | 2024 | 3048 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2015 | 3390 | 0.020 |
Why?
|
Drug Therapy | 1 | 2014 | 504 | 0.020 |
Why?
|
Orchiectomy | 1 | 2013 | 466 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1495 | 0.020 |
Why?
|
Biopsy | 2 | 2014 | 6792 | 0.020 |
Why?
|
Endosonography | 1 | 2015 | 626 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2023 | 3604 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2023 | 3941 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2015 | 877 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 2048 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3109 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2040 | 0.020 |
Why?
|
Health Personnel | 1 | 2024 | 3384 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2018 | 1967 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1885 | 0.020 |
Why?
|
Adolescent | 3 | 2015 | 89169 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3211 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1752 | 0.020 |
Why?
|
Stroke Volume | 1 | 2023 | 5622 | 0.020 |
Why?
|
Lung | 1 | 2008 | 10101 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3912 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2019 | 65379 | 0.020 |
Why?
|
Computer Simulation | 1 | 2003 | 6283 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1906 | 0.020 |
Why?
|
Radiotherapy | 1 | 2016 | 1502 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2015 | 2357 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2050 | 0.020 |
Why?
|
Young Adult | 4 | 2015 | 60066 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2540 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1628 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 17142 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3968 | 0.020 |
Why?
|
Necrosis | 1 | 2011 | 1616 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3670 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2015 | 2062 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11095 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12840 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4428 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2735 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2015 | 5315 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8080 | 0.010 |
Why?
|
Liver | 1 | 2019 | 7578 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14783 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 13053 | 0.010 |
Why?
|
Child | 1 | 2011 | 80917 | 0.010 |
Why?
|
Algorithms | 1 | 2023 | 14164 | 0.010 |
Why?
|
North Carolina | 1 | 2003 | 329 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21538 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8648 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13490 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 13091 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13668 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10840 | 0.010 |
Why?
|
Glioma | 1 | 2015 | 3503 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7454 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54924 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18349 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10478 | 0.010 |
Why?
|
United States | 2 | 2019 | 73039 | 0.010 |
Why?
|
Health Behavior | 1 | 2007 | 2650 | 0.010 |
Why?
|
Melanoma | 1 | 2014 | 5706 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2007 | 3231 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9118 | 0.010 |
Why?
|
Animals | 2 | 2018 | 169285 | 0.010 |
Why?
|
Mice | 1 | 2018 | 82049 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 40220 | 0.010 |
Why?
|